1-8 of 8
Scott McKenzie, MD
Close
Sort by
Journal Articles

Pre- and Post-National Coverage Determination (NCD) Hematologic Outcomes and Blood Utilization in Cancer Patients with Chemotherapy-Induced Anemia (CIA): Results From a Multicenter Chart Review.

David H. Henry, MD, Corey J. Langer, MD, FACP, R. Scott McKenzie, MD, Catherine Tak Piech, MBA, Mekré Senbetta, PharmD, Kathy L. Schulman, MA, Edward J. Stepanski, PhD
Journal: Blood
Blood (2009) 114 (22): 2491.
https://doi.org/10.1182/blood.V114.22.2491.2491
Published: 2009
Journal Articles

Blood and Resource Utilization in Cancer Patients with Chemotherapy-Induced Anemia (CIA) in the Pre- and Post-National Coverage Determination (NCD) Timeframes: Results From An Electronic Medical Record Study.

Tanya Burton, PhD, Luke Boulanger, MA, MBA, Kay Larholt, ScD, Chris L. Pashos, PhD, R. Scott McKenzie, MD, Mekré Senbetta, PharmD, Janice Lopez, PharmD, Devi Sundaresan, MS, Peggy Preusse, RN, Christopher Seidler, MD
Journal: Blood
Blood (2009) 114 (22): 2472.
https://doi.org/10.1182/blood.V114.22.2472.2472
Published: 2009
Journal Articles

Hematologic and Hospitalization Outcomes in Patients with Chemotherapy-Induced Anemia (CIA) Treated with Erythropoiesis-Stimulating Agents (ESAs) in the Pre- Vs Post-National Coverage Determination (NCD) Time Periods.

Elizabeth Apgar, MPH, Tanya M. Burton, PhD, Kay Larholt, ScD, Chris L. Pashos, PhD, Lorie Ellis, PhD, Mekré Senbetta, PharmD, R. Scott McKenzie, MD
Journal: Blood
Blood (2009) 114 (22): 2482.
https://doi.org/10.1182/blood.V114.22.2482.2482
Published: 2009
Journal Articles

Comparison of Epoetin Alfa and Darbepoetin Alfa Dosing and Costs in an Inpatient Population with Myelodysplastic Syndromes

Marie- Hélène Lafeuille, BA, Francis Vekeman, MA, Robert A. Bailey, MD, R. Scott Mckenzie, MD, Patrick Lefebvre, MA
Journal: Blood
Blood (2008) 112 (11): 1297.
https://doi.org/10.1182/blood.V112.11.1297.1297
Published: 2008
Journal Articles

Pre- vs. Post-National Coverage Determination (NCD) Blood Utilization and Hemoglobin Values among Medicare Patients Treated with Erythropoietic-Stimulating Agents (ESAs) for Chemotherapy-Induced Anemia (CIA)

Tanya Burton, PhD, Kay Larholt, ScD, Elizabeth Apgar, MPH, Chris Pashos, PhD, Brahim Bookhart, MBA, MPH, Mitra Corral, MS, MPH, Catherine Tak Piech, MBA, R. Scott Mckenzie, MD
Journal: Blood
Blood (2008) 112 (11): 1301.
https://doi.org/10.1182/blood.V112.11.1301.1301
Published: 2008
Journal Articles

Patient-Reported Fatigue Scores in Cancer Patients with Chemotherapy-Induced Anemia Treated with Erythropoietic-Stimulating Agents (ESAs).

Tanya Burton, PhD, David Hoaglin, PhD, Kay Larholt, ScD, Elizabeth Apgar, MPH, Chris Pashos, PhD, Brahim Bookhart, MBA, MPH, Mitra Corral, MS, MPH, Catherine Tak Piech, MBA, R. scott McKenzie, MD
Journal: Blood
Blood (2008) 112 (11): 1304.
https://doi.org/10.1182/blood.V112.11.1304.1304
Published: 2008
Journal Articles

Hematologic Outcomes and Erythropoiesis-Stimulating Therapy Costs in Epoetin Alfa (EPO)- and Darbepoetin Alfa (DARB)-Treated Cancer Patients: Results of the Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (D.O.S.E. Registry).

Er Chen, MPP, Cyrus Peake, BPharmSci, Erminia Buscaino, BS, Jamie Forlenza, PharmD, BS, Brahim Bookhart, MBA,MPH, Scott McKenzie, MD
Journal: Blood
Blood (2006) 108 (11): 3340.
https://doi.org/10.1182/blood.V108.11.3340.3340
Published: 2006
Journal Articles

Early Hemoglobin Response to Erythropoiesis-Stimulating Therapies (ESTs) and Outcomes in Cancer Patients with Anemia: Results from a Prospective, Observational Study.

Qin Wang, MA, Kay Larholt, Chris Pashos, Jamie Forlenza, PharmD, BS, Brahim Bookhart, MBA, MPH, Scott McKenzie, MD
Journal: Blood
Blood (2006) 108 (11): 3358.
https://doi.org/10.1182/blood.V108.11.3358.3358
Published: 2006